Skip to content

Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19

Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080901001165N48
Enrollment
100
Registered
2020-04-22
Start date
2020-03-30
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Covid-19

Interventions

Intervention 1: Intervention group: Syrup Zofa 10 ml every 8 hours, for 7 days. (In addition to routine treatment according to the latest national guideline for the treatment of new corona-virus). Int

Sponsors

Niak pharmaceutical company
Lead Sponsor
Vice Chancellor for Research, Baqiyatallah University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: age equal or more than 18 years; The patient have written consciously and freely consent to participate in the study. Confirmed diagnosis of COVID-19, with Laboratory (RT-PCR) confirmation. Confirmed diagnosis of COVID-19, with lung CT-Scan result, which is typical for COVID-19 pulmonary involvement. The patient has clinical symptom of COVID-19 (dry cough, respiratory distress, fever) Less than 7 days have passed since the onset of symptoms;

Exclusion criteria

Exclusion criteria: The patient is in another clinical trial at the same time. The patient needs to receive medical care from the intensive care unit

Design outcomes

Primary

MeasureTime frame
Clinical symptoms (dry cough). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Physical examination,questionnaire.;Clinical symptoms (respiratory distress). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: pulse oxymetery device.;Clinical symptoms (fever). Timepoint: Daily monitoring, but the result of baseline (before the initiation of intervention), and day 7 from the initiation, is recorded. Method of measurement: Thermometer.

Secondary

MeasureTime frame
Lab tests changes. Timepoint: daily monitoring, but the before the intervention initiation (baseline) and day 7 results will recorded on designed checklist. Method of measurement: blood sample, laboratory analysis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ghazvini

Bagheiat-allah University of Medical Sciences

qazvinia@gmail.com+98 21 8245 5393

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026